• Go to navigation
  • Go to content
Patient Health International

You are here

  • Home
  • Venous Thromboembolism (VTE)
  • Fact and figures

Astrazeneca global websites

  • AstraZeneca Websites

Main navigation

  • Home
  • News & feature articles
  • Body map
  • List of health conditions
  • Fibroids
  • Interactive area
  • Interactive learning
  • About medicines
  • AstraZeneca medicines
  • About clinical trials
  • Glossary
  • Links
  • Sitemap

Facts & figures on deep vein thrombosis and pulmonary embolism



  • Venous thromboembolism (VTE) includes deep vein thrombosis (DVT) and pulmonary embolism (PE).

  • Around 50% of people with deep vein thrombosis or pulmonary embolism do not have any symptoms.

  • It is estimated that 1 in 1000 people (of the general population) develop symptoms of deep vein thrombosis and 1 in 2000 people develop symptoms of pulmonary embolism.

  • 80% of patients do not exhibit symptoms of DVT, and signs of PE are seen in less than 25% of those diagnosed.

  • Over 2 million people in Europe and the US undergo orthopaedic surgery, involving either total hip replacement or total knee replacement surgery, each year.

  • Without preventative measures, 40-80% of hospitalised patients, who are undergoing orthopaedic surgery, would develop deep vein thrombosis without showing any symptoms. 2-5% would develop symptoms of venous thromboembolism.

  • Almost one third of patients who have experienced venous thromboembolism, develop it again within 8 years of the initial event.
  • Advanced search

Quick links

  • Investor information
  • Press information
  • AstraZeneca US

Page tools

  • Print
  • Bookmark this page

Related links

  • Other countries

List of conditions

AstraZeneca medicines

AstraZeneca International

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2009